Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01004887 · ClinicalTrials.gov registry record
Study of Tissue and Blood Samples From Patients With High-Grade Glioma
A clinical trial of Brain and Central Nervous System Tumors, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 631
- Enrollment target
- 20
- Study locations
NCT01004887: Completed study of Brain and Central Nervous System Tumors, sponsored by Alliance for Clinical Trials in Oncology.
NCT01004887 is a study of Brain and Central Nervous System Tumors that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 631 participants, above the 170-participant average among 45 other Brain and Central Nervous System Tumors trials with a reported enrollment target (271% higher). The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01004887, a study of Brain and Central Nervous System Tumors, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 631 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at tissue and blood samples from patients with high-grade glioma.
Conditions Studied
Interventions
- OTHER diagnostic laboratory biomarker analysis
Study Locations (20)
Illinois
- Illinois CancerCare - Bloomington - Bloomington
- St. Joseph Medical Center - Bloomington
- Graham Hospital - Canton
- Illinois CancerCare - Canton - Canton
- Illinois CancerCare - Carthage - Carthage
- Memorial Hospital - Carthage
- Eureka Community Hospital - Eureka
- Illinois CancerCare - Eureka - Eureka
- Galesburg Clinic, PC - Galesburg
- Illinois CancerCare - Galesburg - Galesburg
- Illinois CancerCare - Havana - Havana
- Mason District Hospital - Havana
- Illinois CancerCare - Kewanee Clinic - Kewanee
- Illinois CancerCare - Macomb - Macomb
- McDonough District Hospital - Macomb
- Trinity Cancer Center at Trinity Medical Center - 7th Street Campus - Moline
Arizona
- Mayo Clinic Scottsdale - Scottsdale
Connecticut
- Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center - Hartford
Florida
- Mayo Clinic - Jacksonville - Jacksonville
Idaho
- Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center - Boise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 631 participants |
| Start Date | 1995-11 |
| Est. Completion | 2019-01-15 |
What the finished NCT01004887 record still lists
NCT01004887 is an observational study that tracks outcomes without assigning an intervention. The registered 631 participants enrollment target is mid-sized for trials with a published cap, above the 170-participant average among 45 other Brain and Central Nervous System Tumors trials with a reported enrollment target (271% higher).
The record links to 1 condition, with Brain and Central Nervous System Tumors appearing as the primary indexed condition, and to 1 intervention - of which diagnostic laboratory biomarker analysis is the first listed.
NCT01004887 names 20 study sites across 5 states, led by Illinois, Arizona, Connecticut.
Frequently Asked Questions
What is clinical trial NCT01004887 about?
NCT01004887 is a clinical study titled "Study of Tissue and Blood Samples From Patients With High-Grade Glioma". RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research st...
What is the current status of trial NCT01004887?
This trial is currently completed. The enrollment target is 631 participants. The study started on 1995-11. Estimated completion is 2019-01-15.
What conditions does trial NCT01004887 study?
This clinical trial studies the following conditions: Brain and Central Nervous System Tumors.
What interventions are being tested in trial NCT01004887?
The interventions under investigation include: diagnostic laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01004887?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01004887 being conducted?
This trial has 20 study locations across Arizona, Connecticut, Florida, Idaho, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain and Central Nervous System Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01004887's enrollment target sits among peer trials
631 3rd of 45 higher than 43 of 45 other Brain and Central Nervous System Tumors trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain and Central Nervous System Tumors trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
RECRUITING
-
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
ACTIVE NOT RECRUITING · Phase 3
-
Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)
ACTIVE NOT RECRUITING · Phase 3
-
Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma
ACTIVE NOT RECRUITING · Phase 2
-
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
ACTIVE NOT RECRUITING · Phase 3
-
Developing Interview Questions to Estimate Workplace Exposure to Electric and Magnetic Fields
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05744973 · 631 participants
Multi-level Predictors of Structural Racism and Discrimination and Associations With Health and Well-being Across the Life Course in Diverse Families
- NCT04704921 · 630 participants · Phase 2
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- NCT04707729 · 630 participants · NA
ROX Index for the Timing of Intubation in Nasal High Flow
- NCT05061550 · 630 participants · Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia